Skip to main content
. Author manuscript; available in PMC: 2022 Apr 12.
Published in final edited form as: Lancet Respir Med. 2014 Apr 10;2(6):464–471. doi: 10.1016/S2213-2600(14)70060-8

Table 1:

Characteristics of eligible cases

Cases (n=325)
Age (months)
Median (range) 13·3 (2·6–53·1)
Clinical syndrome
Meningitis 158 (49%)
Bacteraemic pneumonia 129* (40%)
Pneumonia with effusion 36 (11%)
Bacteraemia 2 (<1%)
Method of detection
Culture of isolate 307 (94%)
PCR of cerebrospinal fluid or pleural fluid 18 (6%)
Serotype
Vaccine-type 151 (46%)
Vaccine-related§ 77 (24%)
Non-vaccine 97 (30%)
Medical care
Outpatient 17 (5%)
Admitted to hospitalised without intensive care 187 (58%)
Admitted to hospitalised with intensive care 121 (37%)
Deaths (outcome)
Overall 77 (24%)
In cases of meningitis 57 (36%)
In cases of pneumonia 19 (12%)
In cases of bacteraemia 1 (50%)

Data are number (%), unless otherwise indicated. PCV10=ten-valent pneumococcal conjugate vaccine.

*

Includes eight cases with Streptococcus pueumoniae detected in both blood and pleural fluid.

Without pneumonia, meningitis, and sepsis.

PCV10 serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F.

§

Serotypes not included in PCV10, but in the same serogroup as any of the included serotypes.

Serotypes not included in PCV10 and not in the same serogroup as any of the included serotypes.